Oak Associates’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Hold
20,450
0.03% 119
2026
Q1
$476K Buy
+20,450
New +$440K 0.03% 116
2020
Q4
Sell
-23,735
Closed -$248K 138
2020
Q3
$248K Hold
23,735
0.02% 128
2020
Q2
$332K Hold
23,735
0.02% 115
2020
Q1
$279K Sell
23,735
-325
-1% -$4.3K 0.02% 112
2019
Q4
$341K Hold
24,060
0.02% 139
2019
Q3
$254K Hold
24,060
0.02% 140
2019
Q2
$350K Hold
24,060
0.02% 138
2019
Q1
$338K Sell
24,060
-6,015
-20% -$97.4K 0.02% 143
2018
Q4
$525K Hold
30,075
0.04% 118
2018
Q3
$458K Hold
30,075
0.03% 146
2018
Q2
$415K Hold
30,075
0.03% 144
2018
Q1
$501K Buy
+30,075
New +$464K 0.03% 127

Other funds holding INVA

Oak Associates's INVA Position: Q2 2026 in Review

Oak Associates held its Innoviva (INVA) position steady in Q2 2026 at 20,450 shares worth $464K. The position accounts for 0.03% of the portfolio, ranked #119.

Oak Associates first reported a position in INVA in Q1 2018 and has held it in 13 quarters since. The position peaked at $525K in Q4 2018. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Oak Associates held 20,450 shares of Innoviva worth $464K as of Q2 2026.
  • Oak Associates left its Innoviva share count unchanged in Q2 2026.
  • Innoviva made up 0.03% of Oak Associates's portfolio in Q2 2026, its #119 holding.
  • Oak Associates first reported a position in Innoviva in Q1 2018 and has held it in 13 quarters since.
  • Oak Associates's Innoviva position peaked at $525K in Q4 2018.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Oak Associates's 13F filing for Q2 2026, filed 14 Aug 2026.